Medibank Pvt Ltd (ASX: MPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medibank Pvt Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$13.08 billion
P/E Ratio
26.65
Dividend Yield
3.71%
Shares Outstanding
2.75 billion
Earnings per share
0.182
Dividend per share
0.18
Year To Date Return
1.25%
Earnings Yield
3.75%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medibank Pvt Ltd (ASX: MPL)
Latest News
Healthcare Shares
Medibank shares fall despite big 2030 transformation plans
Dividend Investing
I'd buy 12,000 shares of this ASX stock to aim for $200 a month of passive income
Broker Notes
Does Macquarie prefer Medibank Private or NIB shares?
Blue Chip Shares
2 ASX blue-chip shares offering big dividend yields
Share Fallers
Why 4DMedical, Iluka, Medibank, and Pilbara Minerals shares are sinking today
Share Market News
5 things to watch on the ASX 200 on Wednesday
Dividend Investing
35 ASX shares with ex-dividend dates next week
Healthcare Shares
ASX health insurance shares: Does Macquarie still prefer NIB over Medibank Private shares?
Healthcare Shares
Medibank shares dive 6% despite dividend hike
Financial Shares
Up 33% this year, does Macquarie rate Medibank Private shares a buy, hold or sell?
Dividend Investing
2 ASX dividend champions that never cut payouts
Blue Chip Shares
2 ASX blue-chip shares offering big dividend yields
Frequently Asked Questions
-
Medibank Private was established by the Australian government in 1976 as a not-for-profit private health insurer. It converted into a for-profit entity in 2009 before listing on the ASX in November 2014.
-
Yes, Medibank Private has paid dividends to shareholders every year since 2015. Typically, it pays an interim dividend in March and a final dividend in September, both fully franked.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 10 Sep 2025 | $0.1020 | 100.00% | Final | 09 Oct 2025 |
| 06 Mar 2025 | $0.0780 | 100.00% | Interim | 26 Mar 2025 |
| 04 Sep 2024 | $0.0940 | 100.00% | Final | 26 Sep 2024 |
| 29 Feb 2024 | $0.0720 | 100.00% | Interim | 20 Mar 2024 |
| 13 Sep 2023 | $0.0830 | 100.00% | Final | 05 Oct 2023 |
| 02 Mar 2023 | $0.0630 | 100.00% | Interim | 22 Mar 2023 |
| 07 Sep 2022 | $0.0730 | 100.00% | Final | 29 Sep 2022 |
| 04 Mar 2022 | $0.0610 | 100.00% | Interim | 24 Mar 2022 |
| 08 Sep 2021 | $0.0690 | 100.00% | Final | 30 Sep 2021 |
| 03 Mar 2021 | $0.0580 | 100.00% | Interim | 25 Mar 2021 |
| 02 Sep 2020 | $0.0630 | 100.00% | Final | 24 Sep 2020 |
| 03 Mar 2020 | $0.0570 | 100.00% | Interim | 26 Mar 2020 |
| 04 Sep 2019 | $0.0740 | 100.00% | Final | 26 Sep 2019 |
| 05 Mar 2019 | $0.0570 | 100.00% | Interim | 28 Mar 2019 |
| 05 Sep 2018 | $0.0720 | 100.00% | Final | 27 Sep 2018 |
| 06 Mar 2018 | $0.0550 | 100.00% | Interim | 28 Mar 2018 |
| 06 Sep 2017 | $0.0000 | 100.00% | Final | 28 Sep 2017 |
| 07 Mar 2017 | $0.0525 | 100.00% | Interim | 29 Mar 2017 |
| 06 Sep 2016 | $0.0600 | 100.00% | Final | 28 Sep 2016 |
| 04 Mar 2016 | $0.0500 | 100.00% | Interim | 29 Mar 2016 |
MPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medibank Pvt Ltd
Previously owned by the Australian government, Medibank Private Ltd (ASX: MPL) is the largest health insurer in Australia.
As of November 2022, its two brands, Medibank Private and ahm, provide cover to almost five million people.
Medibank and Australia's fourth-largest health fund, NIB Holdings Limited (ASX: NIB), are the only health insurers listed on the ASX.
In addition to private health insurance, the company provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
MPL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Jan 2026 | $4.75 | $0.00 | 0.00% | 4,933,131 | $4.76 | $4.78 | $4.73 |
| 12 Jan 2026 | $4.75 | $-0.10 | -2.06% | 5,414,463 | $4.80 | $4.89 | $4.69 |
| 09 Jan 2026 | $4.85 | $0.06 | 1.25% | 5,117,469 | $4.83 | $4.85 | $4.79 |
| 08 Jan 2026 | $4.79 | $0.04 | 0.84% | 6,058,017 | $4.70 | $4.80 | $4.70 |
| 07 Jan 2026 | $4.75 | $0.07 | 1.50% | 4,373,009 | $4.65 | $4.76 | $4.64 |
| 06 Jan 2026 | $4.68 | $-0.07 | -1.47% | 4,859,400 | $4.72 | $4.74 | $4.67 |
| 05 Jan 2026 | $4.75 | $-0.06 | -1.25% | 3,520,161 | $4.78 | $4.80 | $4.74 |
| 02 Jan 2026 | $4.81 | $0.02 | 0.42% | 2,022,662 | $4.79 | $4.83 | $4.79 |
| 31 Dec 2025 | $4.79 | $-0.02 | -0.42% | 1,806,150 | $4.81 | $4.82 | $4.78 |
| 30 Dec 2025 | $4.81 | $0.06 | 1.26% | 2,955,344 | $4.78 | $4.84 | $4.78 |
| 29 Dec 2025 | $4.75 | $-0.02 | -0.42% | 3,628,534 | $4.76 | $4.80 | $4.75 |
| 24 Dec 2025 | $4.77 | $-0.06 | -1.24% | 1,814,381 | $4.78 | $4.80 | $4.75 |
| 23 Dec 2025 | $4.83 | $0.06 | 1.26% | 4,927,751 | $4.75 | $4.83 | $4.74 |
| 22 Dec 2025 | $4.77 | $0.01 | 0.21% | 3,070,122 | $4.76 | $4.79 | $4.75 |
| 19 Dec 2025 | $4.76 | $-0.02 | -0.42% | 12,151,969 | $4.78 | $4.80 | $4.76 |
| 18 Dec 2025 | $4.78 | $0.00 | 0.00% | 5,594,602 | $4.79 | $4.83 | $4.76 |
| 17 Dec 2025 | $4.78 | $-0.01 | -0.21% | 6,373,723 | $4.75 | $4.81 | $4.70 |
| 16 Dec 2025 | $4.79 | $0.02 | 0.42% | 7,346,110 | $4.79 | $4.82 | $4.75 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 23 Dec 2025 | David Koczkar | Transfer | 535,832 | $2,550,560 |
Off-market transfer.
|
| 23 Dec 2025 | David Koczkar | Transfer | 535,832 | $2,550,560 |
Off-market transfer.
|
| 12 Dec 2025 | David Koczkar | Issued | 724,646 | $3,398,589 |
Issue of securities. 2,275,601 Performance Rights
|
| 04 Sep 2025 | David Koczkar | Expiry | 228,855 | $1,148,852 |
As advised by the company. lapsed Performance Rights. 1,550,955 Rights
|
| 04 Sep 2025 | David Koczkar | Exercise | 534,919 | $2,685,293 |
Conversion of securities. 1,779,810 Rights
|
| 04 Sep 2025 | David Koczkar | Buy | 535,832 | $2,689,876 |
Conversion of securities.
|
| 01 Sep 2025 | Jay Weatherill | Buy | 5,900 | $30,031 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Michael (Mike) John Wilkins | Non-Executive DirectorNon-Executive Chairman | May 2017 |
Mr Wilkins has more than 30 years of experience in financial services, predominantly in Australia and Asia. He is member of Investment and Capital Committee.
|
| Ms Kathryn Joy Fagg | Non-Executive Director | Mar 2022 |
Ms Fagg is a director and Chair with several senior commercial and operational experience.
|
| Dr Lisa Margaret McIntyre | Non-Executive Director | Nov 2025 |
--
|
| Ms Jacqueline Cherie Hey | Non-Executive Director | Nov 2025 |
--
|
| Mr David Koczkar | Chief Executive OfficerManaging Director | May 2021 |
Mr Koczkar has over 25 years of strategy, customer, commercial and operational experience across Australia, Asia and the UK, including previous work in the consulting and financial services industries.
|
| Mr Peter Dobie Everingham | Non-Executive Director | Mar 2022 |
Mr Everingham has over 25 years of corporate experience in the digital sector, having held senior executive roles in that sector for 18 years. His senior leadership experience includes roles at companies with a consumer and technology focus. He is member of Investment and Capital Committee.
|
| Dr Tracey Leigh Batten | Non-Executive Director | Aug 2017 |
Dr Batten has experience in the health services sector, with strong commercial, strategy and change leadership skills. She is also a member of the Risk Management Committee.
|
| Mr Gerard Dalbosco | Non-Executive Director | May 2021 |
Mr Dalbosco was a partner of EY until September 2020, he held number of senior leadership roles including Oceania Managing Partner and CEO; Asia Pacific Joint Deputy CEO and Managing Partner-Markets; Oceania Managing Partner-Transaction Advisory Services; and Melbourne Managing Partner. Prior to these roles he advised organisations across a range of sectors in respect of merger and acquisitions advice, valuations, and strategic, commercial, and financial due diligence. He is also a member of Risk Management Committee.
|
| Ms Mei Ramsay | Group General CounselCompany Secretary | Mar 2011 |
-
|
| Milosh Milisavljevic | Chief Customer Officer |
-
|
|
| Mark Rogers | Chief Financial Officer and Group Strategy |
-
|
|
| Tom Exton | Chief Risk and Compliance Officer |
-
|
|
| Felicia Trewin | Data and Technology |
-
|
|
| Mei Ramsay | Group General CounselCompany Secretary |
-
|
|
| Rob Read | Group Lead - Amplar Health |
-
|
|
| Kylie Bishop | People Spaces and Sustainability |
-
|
|
| Meaghan Telford | Policy Advocacy and Reputation |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 892,959,467 | 32.42% |
| J P Morgan Nominees Australia Pty Limited | 691,193,311 | 25.10% |
| Citicorp Nominees Pty Limited | 279,602,750 | 10.15% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 53,403,629 | 1.94% |
| BNP Paribas Noms Pty Ltd | 52,018,924 | 1.89% |
| National Nominees Limited | 23,212,018 | 0.84% |
| HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 19,787,507 | 0.72% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 10,400,458 | 0.38% |
| HSBC Custody Nominees (Australia) Limited i | 9,900,707 | 0.36% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 9,459,352 | 0.34% |
| Netwealth Investments Limited <Wrap Services A/C> | 8,145,967 | 0.30% |
| Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> | 5,472,803 | 0.20% |
| Ioof Investment Services Limited <Ips Superfund A/C> | 4,651,005 | 0.17% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 4,251,765 | 0.15% |
| Bond Street Custodians Limited <Cockej F01832 A/C> | 3,645,606 | 0.13% |
| Netwealth Investments Limited <Super Services A/C> | 3,474,013 | 0.13% |
| Solium Nominees (Australia) Pty Ltd <Vsa A/C> | 3,434,210 | 0.12% |
| Ioof Investment Services Limited <Iisl Nal Isma 2 A/C> | 3,413,362 | 0.12% |
| BNP Paribas Noms (Nz) Ltd | 3,358,180 | 0.12% |
| Buttonwood Nominees Pty Ltd | 3,007,154 | 0.12% |
